Atlas Trials

Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer

Clinical trial NCT00290693 · COMPLETED

Trial details

NCT number
NCT00290693
Sponsor
University of Miami
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2004-07-01
Primary completion
2008-08-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.